Literature DB >> 24934496

The non-cardiac use and significance of cardiac troponins.

Gurdeep Singh Mannu1.   

Abstract

Cardiac Troponins are blood markers of myocardial damage and are widely utilised across all acute medical departments. However, with a massive rise in requests for this test, the interpretation of raised serum levels in the absence of cardiac sounding clinical features can become a clinical conundrum. This is especially true if the numerous causes of positive test results are not fully appreciated. A thorough understanding of the strengths and weaknesses of this blood test in light of a patient population living longer, increasing in comorbidities and possible causes of false test results can provide invaluable support in establishing an accurate diagnosis and instigating effective management. This article will describe the history of cardiac markers along with a discussion of the various causes of elevated cardiac troponins outside acute coronary syndrome. It will elaborate on the applications and significance of this blood test and the potential uses of positive results with elevated serum Troponin levels.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Troponin; acute coronary syndrome (ACS); cardiac enzymes; differential diagnosis; myocardium

Mesh:

Substances:

Year:  2014        PMID: 24934496     DOI: 10.1177/0036933014540090

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  7 in total

Review 1.  Of mitochondrion and COVID-19.

Authors:  Khalid Omer Alfarouk; Sari T S Alhoufie; Abdelhameed Hifny; Laurent Schwartz; Ali S Alqahtani; Samrein B M Ahmed; Ali M Alqahtani; Saad S Alqahtani; Abdel Khalig Muddathir; Heyam Ali; Adil H H Bashir; Muntaser E Ibrahim; Maria Raffaella Greco; Rosa A Cardone; Salvador Harguindey; Stephan Joel Reshkin
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

2.  Troponin T in Patients with Traumatic Chest Injuries with and without Cardiac Involvement: Insights from an Observational Study.

Authors:  Ismail Mahmood; Ayman El-Menyar; Wafer Dabdoob; Yassir Abdulrahman; Tarriq Siddiqui; Sajid Atique; Suresh Kumar Arumugam; Rifat Latifi; Hassan Al-Thani
Journal:  N Am J Med Sci       Date:  2016-01

Review 3.  Cardiac troponin for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis.

Authors:  Yu Fan; Menglin Jiang; Dandan Gong; Changfeng Man; Yuehua Chen
Journal:  Biosci Rep       Date:  2018-03-09       Impact factor: 3.840

4.  Impact of more conservative European Society of Cardiology guidelines on the management of patients with acute chest pain.

Authors:  Calvin L Kienbacher; Verena Fuhrmann; Raphael van Tulder; Christof Havel; Wolfgang Schreiber; Susanne Rasoul-Rockenschaub; Thomas Wrba; Harald Herkner; Anton N Laggner; Dominik Roth
Journal:  Int J Clin Pract       Date:  2021-03-15       Impact factor: 2.503

5.  Elevation of troponin I in acute ischemic stroke.

Authors:  Yu-Chin Su; Kuo-Feng Huang; Fu-Yi Yang; Shinn-Kuang Lin
Journal:  PeerJ       Date:  2016-04-11       Impact factor: 2.984

Review 6.  Cardiac Extracellular Vesicles in Normal and Infarcted Heart.

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Int J Mol Sci       Date:  2016-01-05       Impact factor: 5.923

7.  Comparison of urokinase and reteplase thrombolytic treatment in patients with high-risk pulmonary embolism.

Authors:  Yi Zhang; Lan Ma; Qi Fu; Tao Zhao; Rui-Ying Yan; Xing Su
Journal:  Exp Ther Med       Date:  2019-10-31       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.